1.Progress in pitch control in pulp by enzymes.
Tingting MENG ; Lefan MA ; Hongbing LI
Chinese Journal of Biotechnology 2019;35(2):226-235
Pitch deposits have negative effects on product quality, machine performance and production line profitability during pulp and paper manufacture. As traditional pitch control technology cannot provide satisfactory solutions in the pitch deposits, the enzymatic treatment has been rapidly developed for its high efficiency and pollution-free property. In this review, the chemical composition and present form of the pitch in pulp is first introduced, followed by a description of the pitch control enzymes. The emphasis is on the current research on enzymatic solutions to pitch problems, including the reaction mechanism, technology, and the present main problems of lipase, sterol esterases, laccase and lipoxygenase. Finally, the technology prospects in this field are proposed.
Laccase
;
Lipase
;
Lipoxygenase
;
Paper
3.Research progress in drugs targeting 5-lipoxygenase for age-related diseases.
Zhi-Jun LI ; Yan-Hui MA ; Xi-Xi HOU ; Tuan-Li YAO ; Xiang-Yang QIN
Acta Physiologica Sinica 2023;75(6):864-876
With the acceleration of aging society, delaying aging or promoting healthy aging has become a major demand for human health. 5-Lipoxygenase (5-LOX) is a key enzyme catalyzing arachidonic acid into leukotrienes (LTs), which is a potent mediator of the inflammatory response. Previous studies showed that abnormal activation of 5-LOX and overproduction of LTs are closely related to the occurrence and development of aging-related inflammatory diseases. Therefore, inhibiting 5-LOX activation is a possibly potential strategy for treating age-related diseases. In this paper, the latest research progress in 5-LOX activation, 5-LOX in mediating aging-related diseases and its small molecule inhibitors is briefly reviewed to provide scientific theoretical basis and new ideas for the prevention and treatment of aging-related inflammatory diseases.
Humans
;
Arachidonate 5-Lipoxygenase
;
Leukotrienes
;
Arachidonic Acid
;
Aging
;
Lipoxygenase Inhibitors/pharmacology*
4.Arachidonic acid Alox15/12-HETE signaling inhibits vascular calcification.
Ying-Chun HAN ; Ji-Chao ZHANG ; Cong-Cong ZHANG ; Jie DU
Acta Physiologica Sinica 2021;73(4):571-576
This study aims to explore the effects of arachidonic acid lipoxygenase metabolism in vascular calcification. We used 5/6 nephrectomy and high-phosphorus feeding to establish a model of vascular calcification in mice. Six weeks after nephrectomy surgery, vascular calcium content was measured, and Alizarin Red S and Von Kossa staining were applied to detect calcium deposition in aortic arch. Control aortas and calcified aortas were collected for mass spectrometry detection of arachidonic acid metabolites, and active molecules in lipoxygenase pathway were analyzed. Real-time quantitative PCR was used to detect changes in the expression of lipoxygenase in calcified aortas. Lipoxygenase inhibitor was used to clarify the effect of lipoxygenase metabolic pathways on vascular calcification. The results showed that 6 weeks after nephrectomy surgery, the aortic calcium content of the surgery group was significantly higher than that of the sham group (P < 0.05). Alizarin Red S staining and Von Kossa staining showed obvious calcium deposition in aortic arch from surgery group, indicating formation of vascular calcification. Nine arachidonic acid lipoxygenase metabolites were quantitated using liquid chromatography/mass spectrometry (LC-MS) analysis. The content of multiple metabolites (12-HETE, 11-HETE, 15-HETE, etc.) was significantly increased in calcified aortas, and the most abundant and up-regulated metabolite was 12-HETE. Furthermore, we examined the mRNA levels of metabolic enzymes that produce 12-HETE in calcified blood vessels and found the expression of arachidonate lipoxygenase-15 (Alox15) was increased. Blocking Alox15/12-HETE by Alox15 specific inhibitor PD146176 significantly decreased the plasma 12-HETE content, promoted calcium deposition in aortic arch and increased vascular calcium content. These results suggest that the metabolism of arachidonic acid lipoxygenase is activated in calcified aorta, and the Alox15/12-HETE signaling pathway may play a protective role in vascular calcification.
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
;
Animals
;
Arachidonate 12-Lipoxygenase
;
Arachidonate 15-Lipoxygenase/metabolism*
;
Arachidonic Acid
;
Hydroxyeicosatetraenoic Acids
;
Lipoxygenase/metabolism*
;
Mice
;
Signal Transduction
;
Vascular Calcification
5.The Effects of Lipoxygenase and Cyclooxygenase Inhibitors to Meningioma Cell Proliferation in vitro.
Yong Seok PARK ; Tae Heon KOO ; Jung Hoon LEE ; Young Bae LEE ; Kyu Chun LEE ; Jin Ho MOK ; Han Sik KIM
Journal of Korean Neurosurgical Society 2000;29(1):28-34
No abstract available.
Cell Proliferation*
;
Cyclooxygenase Inhibitors*
;
Lipoxygenase*
;
Meningioma*
;
Prostaglandin-Endoperoxide Synthases*
7.Lipoxygenase Inhibitory Activity of Korean Indigenous Mushroom Extracts and Isolation of an Active Compound from Phellinus baumii.
Seung Woong LEE ; Ja Gyeong SONG ; Byung Soon HWANG ; Dae Won KIM ; Yoon Ju LEE ; E Eum WOO ; Ji Yul KIM ; In Kyoung LEE ; Bong Sik YUN
Mycobiology 2014;42(2):185-188
We investigated a total of 335 samples of Korean native mushroom extracts as part of our lipoxygenase (LOX) inhibitor screening program. Among the mushroom-methanolic extracts we investigated, 35 exhibited an inhibitory activity greater than 30% against LOX at a concentration of 100 microg/mL. Especially, Collybia maculata, Tylopilus neofelleus, Strobilomyces confusus, Phellinus gilvus, P. linteus, P. baumii, and Inonotus mikadoi exhibited relatively potent LOX inhibitory activities of 73.3%, 51.6%, 52.4%, 66.7%, 59.5%, 100.0%, and 85.2%, respectively. Bioassay-guided fractionation led to the isolation of inoscavin A from the methanolic extract of P. baumii, which showed the most potent activity and was identified by spectroscopic methods. Specifically, inoscavin A exhibited potent LOX inhibitory activity with an IC50 value of 6.8 microM.
Agaricales*
;
Inhibitory Concentration 50
;
Lipoxygenase*
;
Mass Screening
;
Methanol
8.5-lipoxygenase is involved in rotenone-induced injury in PC12 cells.
Xiao-Yan ZHANG ; Li-Hui ZHANG ; Cheng-Tan LI ; Wen-Jian CHEN ; Jian-Bo ZHAO ; Er-Qing WEI
Journal of Zhejiang University. Medical sciences 2011;40(2):150-155
OBJECTIVETo determine whether 5-lipoxygenase (5-LOX) is involved in rotenone-induced injury in PC12 cells, which is a cell model of Parkinson disease.
METHODSAfter rotenone treatment for various durations, cell viability was determined by colorimetric MTT reduction assay, and 5-LOX translocation was detected by immunocytochemistry. The effect of 5-LOX inhibitor zileuton was also investigated.
RESULTRotenone (0.3-30 μmol/L) induced PC12 cell injury, and zileuton (3-100 μmol/L) attenuated this injury. Rotenone also time-and concentration-dependently induced 5-LOX translocation into the nuclear envelope, and zileuton (1-30 μmo/L) significantly inhibited rotenone-induced 5-LOX translocation.
CONCLUSION5-LOX is involved in rotenone-induced injury in PC12 cells, and 5-LOX inhibitor zileuton can reduce rotenone-induced 5-LOX activation and cell injury.
Animals ; Arachidonate 5-Lipoxygenase ; metabolism ; physiology ; Cell Survival ; drug effects ; Hydroxyurea ; analogs & derivatives ; pharmacology ; Lipoxygenase Inhibitors ; pharmacology ; PC12 Cells ; Rats ; Rotenone ; pharmacology
9.Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts.
Yoshihide KANAOKA ; Joshua A BOYCE
Allergy, Asthma & Immunology Research 2014;6(4):288-295
Cysteinyl leukotrienes (cys-LTs) are potent mediators of inflammation derived from arachidonic acid through the 5-lipoxygenase/leukotriene C4 synthase pathway. The derivation of their chemical structures and identification of their pharmacologic properties predated the cloning of their classical receptors and the development of drugs that modify their synthesis and actions. Recent studies have revealed unanticipated insights into the regulation of cys-LT synthesis, the function of the cys-LTs in innate and adaptive immunity and human disease, and the identification of a new receptor for the cys-LTs. This review highlights these studies and summarizes their potential pathobiologic and therapeutic implications.
Adaptive Immunity
;
Arachidonate 5-Lipoxygenase
;
Arachidonic Acid
;
Asthma
;
Clone Cells
;
Cloning, Organism
;
Humans
;
Inflammation Mediators
;
Leukotrienes*
10.Rhamnazin inhibits LPS-induced inflammation and ROS/RNS in raw macrophages.
Journal of Nutrition and Health 2016;49(5):288-294
PURPOSE: The aim of this work was to investigate the beneficial effects of rhamnazin against inflammation, reactive oxygen species (ROS)/reactive nitrogen species (RNS), and anti-oxidative activity in murine macrophage RAW264.7 cells. METHODS: To examine the beneficial properties of rhamnazin on inflammation, ROS/ RNS, and anti-oxidative activity in the murine macrophage RAW264.7 cell model, several key markers, including COX and 5-LO activities, NO•, ONOO-, total reactive species formation, lipid peroxidation, •O₂ levels, and catalase activity were estimated. RESULTS: Results show that rhamnazin was protective against LPS-induced cytotoxicity in macrophage cells. The underlying action of rhamnazin might be through modulation of ROS/RNS and anti-oxidative activity through regulation of total reactive species production, lipid peroxidation, catalase activity, and •O₂, NO•, and ONOO• levels. In addition, rhamnazin down-regulated the activities of pro-inflammatory COX and 5-LO. CONCLUSION: The plausible action by which rhamnazin renders its protective effects in macrophage cells is likely due to its capability to regulate LPS-induced inflammation, ROS/ RNS, and anti-oxidative activity.
Arachidonate 5-Lipoxygenase
;
Catalase
;
Inflammation*
;
Lipid Peroxidation
;
Macrophages*
;
Nitrogen
;
Reactive Nitrogen Species
;
Reactive Oxygen Species